MoneyWorks4Me

CORONA Remedies secures EAEU-GMP Certification

22 Jan 2026 Evaluate

CORONA Remedies has secured Eurasian Economic Union - Good Manufacturing Practices (EAEU-GMP) Certification for its finished dosage facility situated at Bhayla, Gujarat. This certification paves the way for the company’s entry into five EAEU member nations -- Russia, Kyrgyzstan, Armenia, Belarus, and Kazakhstan -- under a B2B business model. 

It unlocks access to a pharmaceutical market estimated at $25 billion and aligns seamlessly with the company’s long-term vision of fostering sustainable international partnerships. EAEU-GMP certification further strengthens the company’s focus across its four key therapeutic pillars -- Women’s Health, Cardio-Diabetes, Pain Management, and Urology.  

CORONA Remedies is primarily engaged in the business of manufacturing, trading and marketing of pharmaceutical products.

CORONA Remedies Share Price

2129.10 14.30 (0.68%)
19-Aug-2026 10:42 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1890.00
Dr. Reddys Labs. 1184.50
Cipla 1425.90
Lupin 2218.70
Zydus Lifesciences 1119.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: